Copyright
©The Author(s) 2022.
World J Methodol. Jul 20, 2022; 12(4): 200-223
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.200
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.200
Factor | Example | |
Viral-related factors | The viral load[24]; Mutation/virulence; Previous infections with other Coronaviruses e.g., SARS-CoV[43,59] | |
Host-related factors: | Demographic factors | Patients' age[61,62] |
Gender[80,182] | ||
Race/ethnic group | ||
Physiological | Pregnancy[215]; Personel differences in ACE2 receptors distribution[13] | |
Pathological factors | Presence of comorbidities such as obesity, hypertension, tuberculosis, HIV, anemia, nutritional deficiencies, or diabetes mellitus[13,45,159,169,171,181] | |
Immunological factors | The type of HLA-antigen[20-23] | |
The plasma numbers of B cells, T cells, and natural killer lymphocytes[40,41] | ||
The hemoglobin and ferritin levels[216] | ||
The levels of C3 and C4[38] | ||
The differences in the MBL protein[28] | ||
Environmental factors | Socioeconomic status[217] | |
Overcrowding[218] | ||
Smocking[205] | ||
Alcohol consumption[204] | ||
Particular occupations: Occupations that involve a higher degree of physical proximity to others over long periods[219] | ||
Pharmacological factors | Certain drugs increase the severity (e.g., rituximab, high-dose corticosteroid)[140,187,191]. Certain drugs decrease the severity (e.g., ubiquinone, ezetimibe, flecainide, rosuvastatin, artificial tears, licorice)[214] | |
Vaccination status of the patients |
- Citation: Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol 2022; 12(4): 200-223
- URL: https://www.wjgnet.com/2222-0682/full/v12/i4/200.htm
- DOI: https://dx.doi.org/10.5662/wjm.v12.i4.200